Login

Insights for a Different World: Arjan Meijer on Aviation's Future | Arjan Meijer - CEO of Embraer 00:10:00

Share On Facebook Share On Twitter

Arjan Meijer is Pres/CEO:Commercial Aviation at Embraer SA.

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Their Superpower Is Science, Says Dr. Hyun Jung Cho | Hyun-Jung Cho, CEO, BITComputer3285K:KOE
00:10:00
Candles Scandinavia CEO Viktor Garmiani Discusses Q1 Performance: Tackling Disruptions and Optimizing Production | Viktor Garmiani, CEO , Candles Scandinavia AB.
00:10:00
Over $6B assets under management, 31 IPOs, and 80+ acquisitions|Rodolfo Gonzalez,General Partner,Foundation Capital
00:10:00
Celebrating a decade of growth and success, multi-brand franchisor anticipates continued expansion | Stephen Hemsley, CEO, Franchise Brands PLC.
00:10:00
Pursuing energy transition opportunities such as renewables and electrification|Pawel Chudzinski,Partner,Point Nine
00:10:00
Overview of the Copper Market and Future Trends
00:10:00
The Inspiration Behind Timothy Financial Counsel: Mark Berg's Journey | Mark Berg, Principal , Timothy Financial Counsel.
00:10:00
Prosperity Planning: Smart Savings, Debt Control, and Protection Planning
00:10:00
Copper Bank Corp.: Strategic Focus on Non-Dilutive, High-Yield Copper Investments
00:10:00
Expertise and Efficiency in Offshore Operations: An Interview with Donald Kellogg in Aberdeen
00:10:00
Johanna Barr of Advent International Shares Insights on Private Equity Trends and Opportunities at IPM Conference|Johanna Barr - Managing Director, Advent International
00:10:00
Capital Markets Issuances: Insights from Daniel D. Camacho

© 2017 - Neuhu+